SUN-668 Elevated Osmolal Gap in Long-Term Complication of Type 2 Diabetes

Abstract Osmolal gap (OG) is the difference between the measured osmolality and calculated osmolality estimated by using the mathematical equation. Elevated OG indicates the presence of osmotically active particles undetected in the plasma of healthy individuals. Elevated OG has been observed in multiorgan trauma as a useful prognostic factor of patient survival [1, 2]. We hypothesized that elevated OG may occur in patients with type 2 diabetes (T2D) and may become a useful indicator of unmeasured endotoxins. One of the major mechanisms of this phenomenon may be non-enzymatic glycation of proteins in hyperglycemia, in which the osmotic active carbonyl compounds such as glyoxal, methylglyoxal, and 3-deoxyglucosone, are formed. Testing was performed for participants with T2D, aged 18 to 85. The osmolality measurement was performed with venous blood using the osmometer. The concentration of individual osmols (sodium, potassium, glucose, urea) was determined and on this basis, osmolality was calculated using the Dorwart-Chalmers formula: osmolality (mOsm/kg H2O) = 1.86 x [Na+] + glucose + urea + 9 (Dorwart, 1975). The clinical profile of patients was established based on history and physical examination (age, sex, age, duration of T2D, complications of T2D, HbA1c, LDL-cholesterol, triglyceride, BMI, coexisting diseases, medication). Data were analyzed using descriptive statistics. This study is currently ongoing, but preliminary data from the pilot study suggest an increased mean measured osmolality as well as elevated OG in patients with T2D compared to the reference values for healthy adults. These values differed depending on the type of long-term complications and the duration of the disease. In the pilot study, the highest OG was reported in diabetic retinopathy. A follow-up study with a larger sample may have a better ability to detect the statistical significance of the association of OG and complications of T2D. The association of the osmolal gap and complication of type 2 diabetes is poorly understood, and further investigation is warranted. References: [1] Inaba, H., Hirasawa, H., Mizuguchi, T. (1987), Serum Osmolality Gap In Postoperative Patients In Intensive Care. Lancet, 329 (8546): 1331-1335. [2] Hirasawa, H., Odaka, M., Sugai, T., Ohtake, Y., Inaba, H., Tabata, Y., Kobayashi, H. and Isono, K. (1988), Prognostic Value of Serum Osmolality Gap in Patients with Multiple Organ Failure Treated with Hemopurification. Artificial Organs, 12: 382-387.